miR-26b suppressed cervical cancer cell proliferation and apoptosis by targeting ATF2 through MAPK1/ERK2 pathway
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Minerva endocrinologica - 44(2019), 4 vom: 30. Dez., Seite 405-407 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Xiao, Yan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ATF2 protein, human |
|---|
| Anmerkungen: |
Date Completed 22.06.2020 Date Revised 22.06.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.23736/S0391-1977.19.03068-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM302320539 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM302320539 | ||
| 003 | DE-627 | ||
| 005 | 20231225110455.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.23736/S0391-1977.19.03068-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1007.xml |
| 035 | |a (DE-627)NLM302320539 | ||
| 035 | |a (NLM)31625711 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Xiao, Yan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a miR-26b suppressed cervical cancer cell proliferation and apoptosis by targeting ATF2 through MAPK1/ERK2 pathway |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.06.2020 | ||
| 500 | |a Date Revised 22.06.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a ATF2 protein, human |2 NLM | |
| 650 | 7 | |a Activating Transcription Factor 2 |2 NLM | |
| 650 | 7 | |a MIRN26A microRNA, human |2 NLM | |
| 650 | 7 | |a MicroRNAs |2 NLM | |
| 650 | 7 | |a MAPK1 protein, human |2 NLM | |
| 650 | 7 | |a EC 2.7.11.24 |2 NLM | |
| 650 | 7 | |a Mitogen-Activated Protein Kinase 1 |2 NLM | |
| 650 | 7 | |a EC 2.7.11.24 |2 NLM | |
| 700 | 1 | |a Wang, Li |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Liu |e verfasserin |4 aut | |
| 700 | 1 | |a Yu, Xiao |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, Shuxia |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Fei |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, Huijun |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Minerva endocrinologica |d 1993 |g 44(2019), 4 vom: 30. Dez., Seite 405-407 |w (DE-627)NLM012649112 |x 1827-1634 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2019 |g number:4 |g day:30 |g month:12 |g pages:405-407 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.23736/S0391-1977.19.03068-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2019 |e 4 |b 30 |c 12 |h 405-407 | ||